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Introduction
Protein structure solution using X-ray crystallography can only succeed if a suitable model is available or experimental phases can be obtained. Although molecular replacement has proven to be a powerful technique, it often shows model bias at medium and low resolution and can only be applied if a similar structure is already known. The traditional experimental phasing method is MIR (multiple isomorphous replacement), which involves soaking the crystals with several different heavy-atom reagents. It can suffer from difficulties in obtaining suitable heavy-atom derivatives and lack of isomorphism. The SAD (single-wavelength anomalous dispersion) and MAD (multiple-wavelength anomalous dispersion) methods for experimental phasing have evolved substantially in recent years. Although S or metal atoms, if present in the native protein, can provide phase information, particularly high-quality data are required for sulfur-SAD phasing because of the weak anomalous signal. Where it is possible to express a selenomethionine (SeMet) mutant this often enables the structure to be solved by MAD or SAD methods (Ogata, 1998; Dambe et al., 2006) and, in principle, the same applies to the use of brominated nucleobases for DNA structures (Escalante et al., 1998) , although especially in the latter case radiation damage can be a limiting factor. Anomalously scattering atoms can also be introduced by other chemical modifications of the protein or nucleic acid (Xie et al., 2004; Miyatake et al., 2006) .
A less demanding approach to SAD or MAD phasing is to soak crystals in a heavy-atom solution to incorporate anomalous scatterers such as mercury (Boggon & Shapiro, 2000) , uranium (Wernimont et al., 2000) , iodine (Dauter et al., 2000) or a tantalum bromide cluster (Szczepanowski et al., 2005) into the crystal lattice. However, most heavy-metal ion soaks suffer from nonspecific binding of the heavy atoms, resulting in many binding sites that are not occupied in every unit cell. This leads to a weak anomalous signal and disruption of the crystal lattice, with loss of isomorphism or even destruction of the crystal. In addition, many such soaks require the use of toxic chemicals and require stringent safety precautions.
We chose the iodine-containing compound 5-amino-2,4,6-triiodoisophthalic acid (hereafter referred to as I3C; Fig. 1a ) as a representative of a new class of derivatives for phasing that combine heavy atoms with functional groups for interaction with proteins and nucleic
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Printed in Singapore -all rights reserved acids. Three functional groups (two carboxylates and one amino group) of I3C interact through hydrogen bonds with the main chain as well as with the side chains of proteins. This results in a relatively high occupancy of the bound ligands. With three I atoms per molecule it provides a strong anomalous signal, even for in-house X-ray sources (the anomalous signal f 00 of iodine is 6.85 e À at the Cu K wavelength). The I atoms form an equilateral triangle (with a side of 6.0 Å ) and thus are readily identified in the heavy-atom substructure. In comparison to other heavyatom reagents, I3C has low toxicity. Its derivatives are employed as X-ray contrast reagents in medical diagnosis (Yu & Watson, 1999) . We have described the synthesis and crystallographic characterization of I3C elsewhere (Beck & Sheldrick, 2008) and it is inexpensive and readily available commercially. Initial indications are that it may be successful over a wide pH range.
Methods

Crystallization and data collection
In this study, the incorporation of I3C into three protein samples by either cocrystallization or soaking was investigated. Stock solutions of I3C were obtained by dissolving the solid material in water, adding double the equimolar amount of sodium hydroxide solution or lithium hydroxide solution to fully deprotonate the carboxyl groups. A 0.2 M sodium I3C solution and a 1 M lithium I3C solution were prepared. Protein crystals were obtained using the sitting-drop vapourdiffusion method.
Hen egg-white lysozyme (129 residues, 14.3 kDa) was crystallized at 293 K by mixing 5 ml 20 mg ml À1 protein solution with an equivalent volume of precipitant containing 0.1 M HEPES pH 7.0, 15%(w/w) PEG 3350 and 8 mM sodium I3C solution. Crystals containing I3C appeared within one week. Data were collected in-house on a MAR345 image-plate detector using Cu K radiation from a MacScience rotating-anode X-ray generator equipped with Osmic optics.
Thaumatin (207 residues, 22.2 kDa) was crystallized at 293 K by mixing 2 ml 40 mg ml À1 protein solution with an equivalent volume of precipitant solution containing 0.05 M ADA pH 6.8 and 0.8 M potassium sodium tartrate. A quick soak (2 min) was performed with mother liquor containing 0.5 M lithium I3C. Data were collected inhouse as for lysozyme.
Porcine pancreatic elastase (240 residues, 25.9 kDa) was crystallized at 277 K by mixing 2 ml 40 mg ml resulted in high-quality starting phases (Table 1) . Model building was carried out with ARP/wARP and REFMAC (Perrakis et al., 1999; Murshudov et al., 1997) as part of the CCP4 suite (Potterton et al., 2003) and Coot (Emsley & Cowtan, 2004) . Refinement was carried out with the SHELX suite (Table 2; Sheldrick, 2008) . Investigations of the data show that only a small multiplicity of data is required to find the heavy-atom positions (Table 1) , although of course the ratio of R anom to R p.i.m. , a measure of the quality of the anomalous signal (Weiss, 2001) , increases with higher multiplicity. Since the heavy atoms form an equilateral triangle, a successful solution is readily identified when inspecting the heavy-atom positions (Fig. 1b) , which facilitates structure solution. It is planned to incorporate a search for triangles and similar patterns into SHELXD, similar to the resolution of 'super-sulfurs' (Debreczeni et al., 2003) ; this should be particularly beneficial for the solution of larger structures.
I3C-binding sites
The molecular structures are similar to those previously reported (e.g. lysozyme, Weiss et al., 2000; thaumatin, Ko et al., 1994; elastase, Wü rtele et al., 2000) , since I3C mostly replaces solvent water molecules in the crystal lattice. Inspection of the I3C sites reveals several modes of interaction. The amino group of I3C forms hydrogen bonds to a main-chain carbonyl O atom (e.g. Fig. 1c) or to a hydrogen-bond acceptor in a side chain (e.g. the O atom of asparagine or glutamine). The carboxylate groups interact with side chains of the protein via hydrogen bonds to donor groups in serine, lysine, tyrosine or threonine residues. The prominent hydrogen bonding of the carboxylate group is its interaction with arginine (Fig. 1d) . Additional hydrogen bonds are also formed to solvent water molecules. These strong interactions lead to relatively high occupancies of the sites (Fig. 2) . The occupancies of I3C were refined with SHELXL to values of 0. 60, 0.32, 0.32 and 0.25 for lysozyme, 0.49, 0.44, 0.27, 0.26 and 0.19 for thaumatin and 0.45, 0.23, 0.21 and 0.16 for elastase. From the limited evidence available, it appears that for incorporation of I3C it will be worth trying both soaking and cocrystallization in practice.
Restraints for refinement with REFMAC (CIF format) or SHELXL, together with coordinates in PDB format for the I3C molecule, may be downloaded from http:// shelx.uni-ac.gwdg.de/tbeck. These are based on the small-molecule crystal structure of I3C (Beck & Sheldrick, 2008) .
Conclusion
I3C represents a new class of compound that may be used for heavy-atom derivatization for SAD or SIRAS (single isomorphous replacement plus anomalous scattering) phasing, combining an easily recognizable arrangement of three anomalous scatterers with functional groups for hydrogen bonding to a protein molecule. Low toxicity and ready commercial availability are further advantages. Recently, I3C was used to solve an unknown structure of a 38 kDa protein that had resisted other phasing attempts (Sippel et al., 2008, in this issue) . It is also possible that the hydrogen donor and acceptor groups might promote crystal growth, since we observed several sites where I3C molecules acted as bridges between different protein molecules (e.g. 
